Dr. Jesse Pines
Two people the same age can age very differently. Biological age testing reveals these hidden differences.
Biological age tests are one of the most talked-about tools in longevity science, commonly discussed on podcasts by Drs. Andrew Huberman, Peter Attia and David Sinclair. The tests promise to measure, at a molecular level, how fast your body is aging, separate from your chronological age.
Patients are drawn to the tests for personalized aging insights. Wellness clinics offer them routinely. Researchers use them as endpoints in prevention and aging studies.
But the excitement has brought confusion about what the tests actually measure. In particular, how to interpret them and whether they justify the price point: $150 to over $1,000 per test, which is not covered by insurance. Some advocates even recommend regular testing to track progress and assess if aging is progressing or reversing (i.e. in the movie Benjamin Button).
1. Biological Age Tests Analyze DNA Methylation Patterns
DNA methylation is a chemical modification that helps regulate gene expression. What makes methylation useful for measuring biological age is that specific methylation sites change predictably over time. When researchers apply statistics to hundreds of these age-sensitive sites, they generate what is termed an “epigenetic clock”, which is strongly correlated with chronological age.
Biological age tests commonly use blood, saliva or urine samples. Blood-based tests are the most accurate while saliva and urine offers easier collection but is more variable.
Much of the real value comes not from the estimate itself but from the gap between biological and chronological age. For example, a 50-year-old with a biological age of 55 has five years of “age acceleration”, which increases the risk of all-cause mortality, heart disease, type 2 diabetes and cognitive decline. These signals are not captured well by routine laboratory tests or imaging, which is part of their appeal.
2. Biological Age Tests Are Evolving
First generation methylation clocks emerged around 2013. The Horvath clock used specific areas of DNA methylation to estimate age across nearly all tissues while the Hannum clock focused on blood markers. These early tools were more precise than earlier aging biomarkers such as telomere length.
Second-generation clocks shifted the focus from predicting chronological age to predicting health. DNA PhenoAge incorporated biomarkers like glucose, albumin and inflammation markers. DNA GrimAge was trained directly on mortality and disease-specific outcomes. These clocks outperform earlier models in predicting cardiovascular disease, mortality and physiological decline.
A third wave of tests—including DunedinPACE—no longer measures accumulated biological age but instead estimates how quickly a person is aging. If earlier clocks behaved like an odometer, DunedinPACE functions as a speedometer.
3. Biological Age Tests Do Predict Outcomes But There Are Limitations
The usefulness of a biological age test depends on what it’s designed to predict. First-generation clocks estimated chronological age extremely well. But that is rarely the clinical question. Later-generation clocks, which predict disease and mortality risk, are more relevant for health assessment.
In large studies, each standard deviation increase in GrimAge acceleration corresponds to an increased risk of 1.4 to 2.2 for major diseases and mortality— independent of traditional risk factors. This is why researchers view these clocks as promising tools for risk stratification.
Still, major limitations remain. Associations between epigenetic aging and specific diseases vary widely. Methylation patterns differ across the body’s tissues, making organ-specific interpretations difficult. Many clocks perform less accurately in underrepresented populations like Hispanics, largely because training datasets were not diverse.
4. What Biological Age Tests Are Actually Measuring Remains An Open Question
Biological age tests strongly correlate with disease risk but what these clocks represent biologically is not yet fully understood. Their signals appear distinct from other hallmarks of aging such as telomere shortening, DNA damage or cellular senescence.
The strongest links connect methylation patterns with nutrient-sensing pathways, mitochondrial function, chronic inflammation and stem cell dynamics. These systems regulate how cells use energy, respond to stress, repair damage and maintain tissue health—all core processes that influence the pace of aging. This suggests epigenetic clocks may track metabolism, repair and inflammation more than accumulated damage.
Many methylation sites used in these models also sit far from genes known to regulate aging. This raises an important possibility: epigenetic age may be a powerful marker of biological aging without being a driver of it. If true, lowering the biological age test may not necessarily lead to the desired effect of actual biological age reversal.
5. Interventions Influence Biological Age Test Results But It’s Unclear What That Means
This is where public interest and commercial marketing have surged. Several diet and lifestyle interventions shift biological age metrics.
A Mediterranean-style diet enriched with polyphenols led to an eight to nine month reduction in epigenetic age in an 18-month study. Omega-3 supplementation shows age acceleration over multiple years. By contrast, smoking accelerates biological age dramatically—often by seven years or more—while physical activity, healthy eating, and weight stability slow aging.
Interpretation of the data is complicated. Some observed changes fall within normal test-retest variability. Many commercial tests also rely on proprietary or undisclosed clocks, making comparisons difficult. And critically, no clinical trial has demonstrated that interventions reducing epigenetic age lead to fewer diseases or longer life.
Take Bryan Johnson, the 48-year-old longevity entrepreneur who spends substantial sums tracking his health and reports biological ages far younger—sometimes by 20 years or more—than his chronological age. While these results likely reflect excellent health behaviors, they cannot tell us whether he will live past 100, 110 or 120. That remains entirely uncertain.
6. Are Biological Age Tests Worth the Cost?
Whether biological age tests are “worth it” depends on what someone hopes to gain. If you enjoy tracking your health, these tests do offer a detailed snapshot of how you appear to be aging. They can motivate behavior change by showing how diet, stress, exercise and smoking shape aging in ways traditional testing doesn’t capture.
In the future, second-generation clocks may eventually serve as tools for risk stratification. For example, a patient with significant age acceleration might warrant closer evaluation for cardiometabolic risk factors. While some physicians may use the test results that way, this approach is investigational.
Biological age tests are not included in guideline-based care. This is in part, why they’re not covered by insurance and you need to pay for them out-of-pocket.
As science advances, this may change. Large longitudinal studies of biological age tests are underway and the field is evolving rapidly. But until researchers close the loop between modifying biological age and improving outcomes, these tests should be seen as optional wellness tools rather than necessary medical assessments.